Contact us : info@bioworlde.com
Home > Product > Antigen-Peptide
SAPAP1 (E817) Peptide BS1864P
Product NameSAPAP1 (E817) Peptide
Catalog No.BS1864P
ApplicationsBlocking
Swiss-ProtO14490
Product1 mg/ml in DI water.
Purification&PuritySynthetic peptide SAPAP1 (E817). (Note: the amino acid sequence is proprietary). The purity is > 98%.
Storage&StabilityStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
SpecificityThis peptide can be used with studies using BS1864 SAPAP1 (E817) pAb.
Browse similar products>>
Size Price
1mg $368
Add to cart My orders
Product Name :
SAPAP1 (E817) Peptide
Applications :
Blocking
Background :
Members of the postsynaptic density-95 (PSD-95)/SAP90 family of membraneassociated guanylate kinase (MAGUK) proteins function as multimodular scaffolds that organize protein-signaling complexes at neuronal synapses. PSD-95/SAP90 binds guanylate kinase-associated protein (GKAP), also designated GK domain-binding protein, DAP-1-α, DAP-1-β, PSD-95 binding protein, PSD-95/SAP90 associated protein, or SAPAP1, through the guanylate kinase domain. SAPAP1 is expressed widely in neurons of the cortex and hippocampus and in the Purkinje and granule cells of the cerebellum. N-terminal splice variants of SAPAP1 are expressed as 95 and 130 kDa proteins. SAPAP1 is localized specifically in the PSD of glutamatergic synapses, consistent with its direct interaction with PSD-95 family proteins.
Alternative Name :
SAPAP2; SAP90/PSD-95-associated protein 2; Disks large-associated protein 2; DLGAP2; DAP-2
Swiss-Prot :
O14490
Product :
1 mg/ml in DI water.
Purification&Purity :
Synthetic peptide SAPAP1 (E817). (Note: the amino acid sequence is proprietary). The purity is > 98%.
Storage&Stability :
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
Specificity :
This peptide can be used with studies using BS1864 SAPAP1 (E817) pAb.
Blocking peptide available as BS1864PP
COPYRIGHT © 2015-2018 Bioworld Technology, Inc. All rights reserved POLYCLONAL AND MONOCLONAL ANTIBODY CENTER